Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.

Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group.

PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015 Mar.

2.

Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.

Nordell AD, McKenna M, Borges ÁH, Duprez D, Neuhaus J, Neaton JD; INSIGHT SMART, ESPRIT Study Groups; SILCAAT Scientific Committee.

J Am Heart Assoc. 2014 May 28;3(3):e000844. doi: 10.1161/JAHA.114.000844.

3.

Single-nucleotide polymorphism-defined class I and class III major histocompatibility complex genetic subregions contribute to natural long-term nonprogression in HIV infection.

Guergnon J, Dalmasso C, Broet P, Meyer L, Westrop SJ, Imami N, Vicenzi E, Morsica G, Tinelli M, Zanone Poma B, Goujard C, Potard V, Gotch FM, Casoli C, Cossarizza A, Macciardi F, Debré P, Delfraissy JF, Galli M, Autran B, Costagliola D, Poli G, Theodorou I, Riva A; GISHEAL Consortium.

J Infect Dis. 2012 Mar 1;205(5):718-24. doi: 10.1093/infdis/jir833. Epub 2012 Jan 11.

4.

Prevalence and risk determinants of HIV-1 and HIV-2 infections in pregnant women in Bissau.

Gianelli E, Riva A, Rankin Bravo FA, Da Silva Te D, Mariani E, Casazza G, Scalamogna C, Bosisio O, Adorni F, Rusconi S, Galli M.

J Infect. 2010 Nov;61(5):391-8. doi: 10.1016/j.jinf.2010.08.012. Epub 2010 Sep 8.

PMID:
20831880
5.

Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT).

Pett SL, Carey C, Lin E, Wentworth D, Lazovski J, Miró JM, Gordin F, Angus B, Rodriguez-Barradas M, Rubio R, Tambussi G, Cooper DA, Emery S; INSIGHT-ESPRIT Study Group.

HIV Med. 2011 Apr;12(4):219-27. doi: 10.1111/j.1468-1293.2010.00875.x. Epub 2010 Aug 31.

6.

Pandemic influenza vaccine in adult HIV-1-infected patients.

Orlando G, Pariani E, Mazza F, Tanzi E, Meraviglia P, Gianelli E, Argenteri B, Amendola A, Galli M, Rizzardini G, Zanetti A.

AIDS. 2010 Aug 24;24(13):2142-3. doi: 10.1097/QAD.0b013e32833cfcb0. No abstract available.

PMID:
20679764
7.

Relations between cardiovascular risk estimates and subclinical atherosclerosis in naive HIV patients: results from the HERMES study.

De Socio GV, Martinelli C, Ricci E, Orofino G, Valsecchi L, Vitiello P, Martinelli L, Quirino T, Maggi P, Bonfanti P; HERMES study group.

Int J STD AIDS. 2010 Apr;21(4):267-72. doi: 10.1258/ijsa.2009.009165.

PMID:
20378899
8.

Interleukin-2 therapy in patients with HIV infection.

INSIGHT-ESPRIT Study Group; SILCAAT Scientific Committee, Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, Cooper DA, Darbyshire J, Emery S, Fox L, Gordin F, Lane HC, Lundgren JD, Mitsuyasu R, Neaton JD, Phillips A, Routy JP, Tambussi G, Wentworth D.

N Engl J Med. 2009 Oct 15;361(16):1548-59. doi: 10.1056/NEJMoa0903175.

9.

Efficacy and safety of boosted and unboosted atazanavir-containing antiretroviral regimens in real life: results from a multicentre cohort study.

Giuntini R, Martinelli C, Ricci E, Vichi F, Gianelli E, Madeddu G, Abeli C, Palvarini L, Penco G, Marconi P, Grosso C, Pellicano G, Bonfanti P, Quirino T.

HIV Med. 2010 Jan;11(1):40-5. doi: 10.1111/j.1468-1293.2009.00740.x. Epub 2009 Aug 3. Erratum in: HIV Med. 2011 Feb;12(2):127.

10.

HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis.

Marchetti G, Riva A, Cesari M, Bellistrì GM, Gianelli E, Casabianca A, Orlandi C, Magnani M, Meroni L, d'Arminio Monforte A, Mussini C, Cossarizza A, Galli M, Gori A; Elvis Study Group.

HIV Med. 2009 Aug;10(7):422-31. doi: 10.1111/j.1468-1293.2009.00710.x. Epub 2009 May 5.

11.

Description of a "trans-Saharan" strain of human T-lymphotropic virus type 1 in West Africa.

Zehender G, Ebranati E, De Maddalena C, Gianelli E, Riva A, Rusconi S, Massetto B, Rankin F, Acurie M, Galli M.

J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):269-73.

PMID:
18398969
12.

Cholesterol levels in HIV-HCV infected patients treated with lopinavir/r: results from the SCOLTA project.

De Socio GV, Bonfanti P, Ricci E, Orofino G, Madeddu G, Penco G, Gianelli E, Martinelli C, Carradori S, Quirino T, Rizzardini G; CISAI Study Group.

Biomed Pharmacother. 2008 Jan;62(1):16-20. Epub 2007 Aug 21.

PMID:
17851026
13.

Disseminated Penicillium marneffei infection in an HIV-positive Italian patient and a review of cases reported outside endemic regions.

Antinori S, Gianelli E, Bonaccorso C, Ridolfo AL, Croce F, Sollima S, Parravicini C.

J Travel Med. 2006 May-Jun;13(3):181-8. Review.

14.

Thrombocytopenia and Plasmodium vivax malaria.

Antinori S, Galimberti L, Gianelli E, Morelli P, Radice A, Acquaviva V, Cigardi B.

Clin Infect Dis. 2005 Oct 15;41(8):1210-1; author reply 1211-2. No abstract available.

15.

Cutaneous leishmaniasis: an increasing threat for travellers.

Antinori S, Gianelli E, Calattini S, Longhi E, Gramiccia M, Corbellino M.

Clin Microbiol Infect. 2005 May;11(5):343-6.

16.

Prospective observational study of fever in hospitalized returning travelers and migrants from tropical areas, 1997-2001.

Antinori S, Galimberti L, Gianelli E, Calattini S, Piazza M, Morelli P, Moroni M, Galli M, Corbellino M.

J Travel Med. 2004 May-Jun;11(3):135-42.

17.

Itraconazole can be effective in the treatment of sporotrichoid leishmaniasis.

Morelli P, Gianelli E, Calattini S, Corbellino M, Antinori S, Meroni L.

J Travel Med. 2004 Sep-Oct;11(5):328-30. No abstract available.

18.

Correlates of risk of adipose tissue alterations and their modifications over time in HIV-1-infected women treated with antiretroviral therapy.

Galli M, Ridolfo AL, Adorni F, Cappelletti A, Morelli P, Massetto B, Piazza M, Gianelli E, Vaccarezza M, Gervasoni C, Moroni M.

Antivir Ther. 2003 Aug;8(4):347-54.

PMID:
14518704
19.

Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study.

Galli M, Cozzi-Lepri A, Ridolfo AL, Gervasoni C, Ravasio L, Corsico L, Gianelli E, Vaccarezza M, Vullo V, Cargnel A, Minoli L, Coronado O, Giacometti A, Antinori A, Antonucci G, D'Arminio Monforte A, Moroni M; LipoICoNa Study.

Arch Intern Med. 2002 Dec 9-23;162(22):2621-8.

PMID:
12456235
20.

Acute parvovirus B19 infection and anemia during Plasmodium falciparum malaria.

Scarlata F, Gianelli E, Miceli S, Galimberti L, Antinori S.

Clin Infect Dis. 2002 Dec 1;35(11):1449-51. No abstract available.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk